Home/Filings/4/0001333277-18-000024
4//SEC Filing

Boudes Pol F 4

Accession 0001333277-18-000024

CIK 0001042074other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 5:08 PM ET

Size

5.4 KB

Accession

0001333277-18-000024

Insider Transaction Report

Form 4
Period: 2018-01-24
Boudes Pol F
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-01-24+125,000125,000 total
    Exercise: $11.69Exp: 2028-01-23Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/4 of the underlying shares on January 1, 2019, and vests as to 1/48 of the underlying shares monthly thereafter.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001454771

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 5:08 PM ET
Size
5.4 KB